The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.

How Bayesian Strategies Can Expedite a Pediatric Clincial Trial Time by 20 - 40%

March 20, 2015

Sometimes a new candidate drug for a pediatric study has already been tested on adults for safety and efficacy. We know that the drug is likely to work quite differently in children, but we do not know the degree to which the effects will be different. As a result, a conventional approach is to discard much of the information that has already gathered during studies of adults, and then to start from scratch with a pediatric trial.

Read More